This proposal follows up the new book Immunization and States: The Politics of Making Vaccines, on which the conveners collaborated. The book focuses on public sector vaccine production in different countries from the nineteenth century onward. It ends with a brief sketch of the discussions and re-considerations provoked by two years of the Covid-19 pandemic. As the first effective Covid- 19 vaccines became available, intense disputes and negotiations arose over monopolies on vaccine production and access to vaccine technologies, unequal global distribution of vaccines, and seemingly widespread distrust of new vaccines
Racing to develop and distribute a vaccine against COVID-19 has proven to be a challenging endeavor....
Recent policy conversations about vaccination programmes primarily target the problem of vaccine hes...
Since the outbreak of the Coronavirus disease 2019 (Covid-19), tremendous efforts have been made by ...
This proposal follows up the new book Immunization and States: The Politics of Making Vaccines, on w...
In late 2019 and early 2020, a new strain of coronavirus, a family of pathogens causing serious resp...
The Covid-19 pandemic has had wide-reaching societal and economic effects and a return to “normal” w...
International audienceGlobally, there has been a move away from national public sector vaccine devel...
Vaccines against SARS-CoV-2 continue to be developed at an astonishingly quick speed and the early o...
This article discusses the medical/therapeutical responses to the COVID-19 pandemic and their politi...
We find ourselves at a momentous turn in the history of vaccines. The COVID-19 pandemic triggered a ...
The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and so...
The biopharmaceutical industry mounted an impressive response to the rapidly evolving COVID-19 pande...
Through an unprecedented research and development process, in early 2021, just one year after the CO...
The scientific evidence is clear; vaccines save lives. Why, then, is there controversy over vaccine ...
Tweetable abstract: Reflections on challenges and promises of COVID-19 vaccine development show oppo...
Racing to develop and distribute a vaccine against COVID-19 has proven to be a challenging endeavor....
Recent policy conversations about vaccination programmes primarily target the problem of vaccine hes...
Since the outbreak of the Coronavirus disease 2019 (Covid-19), tremendous efforts have been made by ...
This proposal follows up the new book Immunization and States: The Politics of Making Vaccines, on w...
In late 2019 and early 2020, a new strain of coronavirus, a family of pathogens causing serious resp...
The Covid-19 pandemic has had wide-reaching societal and economic effects and a return to “normal” w...
International audienceGlobally, there has been a move away from national public sector vaccine devel...
Vaccines against SARS-CoV-2 continue to be developed at an astonishingly quick speed and the early o...
This article discusses the medical/therapeutical responses to the COVID-19 pandemic and their politi...
We find ourselves at a momentous turn in the history of vaccines. The COVID-19 pandemic triggered a ...
The COVID-19 pandemic has shaken the world since early 2020 and its health, social, economic, and so...
The biopharmaceutical industry mounted an impressive response to the rapidly evolving COVID-19 pande...
Through an unprecedented research and development process, in early 2021, just one year after the CO...
The scientific evidence is clear; vaccines save lives. Why, then, is there controversy over vaccine ...
Tweetable abstract: Reflections on challenges and promises of COVID-19 vaccine development show oppo...
Racing to develop and distribute a vaccine against COVID-19 has proven to be a challenging endeavor....
Recent policy conversations about vaccination programmes primarily target the problem of vaccine hes...
Since the outbreak of the Coronavirus disease 2019 (Covid-19), tremendous efforts have been made by ...